New Orleans, LA 3/3/08—Agilent Technologies’ Life Science and Chemical Analysis business (also known as Bio-analytical Measurement) has announced two acquisitions to grow its Materials Science Solutions Unit, which was formed last year (see IBO 04/15/07). Agilent has agreed to acquire TILL Photonics GmbH, a provider of fluorescence microscopy products. The acquisition is expected to close […]
The United States Council for Aid Education’s Voluntary Support of Education (VSE) survey, which tracks data from 1,023 institutions, reports that charitable contributions to US colleges and universities increased 63% in 2007 to $29.75 billion. Twenty institutions raised $7.66 billion in total for 2007, making up 25.8% of all contributions to colleges and universities. The […]
Billerica, MA and Hayward, CA 3/4/08—Milipore has announced that it will exclusively distribute Guava Technologies’ nonclinical flow cytometers within defined fields in North America, Europe and countries in Asia. Millipore will also provide field service and develop cobranded reagent kits. In addition, the companies will jointly develop new instruments.
New Zealand’s Fast Forward plan is designed to transform the economy into a more formidable supplier of high value goods and services. Under the plan, the government will allocate NZ$700 million ($570 million) to the pastoral and food industries. The funding will grow interest over the next 10 to 15 years, and will be valued […]
Mobious, which is developing molecular resonance sequencing technology, joined the X Prize competition last year (see IBO 12/31/07). Covaris entered into a supply and distribution agreement with Applied Biosystems for its S2 sample preparation instrument system for use with Applied Biosystems’ SOLiD DNA sequencer. Microfluidics developer RainDance Technologies appointed Christopher McNary president and CEO. He […]
Sepax Technologies is constructing a 100,000 sq. ft. Chromatography Science building in Changzhou, China to be completed in June 2008 for the production of columns, silica chemistry, polymer resin, bulk media and instruments, as well as for research of natural product separations and Chinese medicine. On January 1, Seika Corporation of America changed its name […]
Waters launched the SystemQT qualification tool, offering automated system-level quantification for Waters HPLC systems in order to reduce compliance test time. ESA Biosciences launched its Coulochem III ECD system with a Boron Doped Diamond electrode for the efficient analysis of sulfur-containing compounds. Varian launched its Pursuit family of Fast LC columns with the release of […]
The UK has awarded a consortium that includes Avecia, Intertek ASG, Lonza, Paraytec and the University of Bradford more than £1 million ($2 million) in grants to develop an instrument to monitor and quantify aggregation at line or online during biopharmaceutical processing.
ICx Technologies released the handheld Fido PaxPoint Liquid Explosives Detector. Innovative Biosensors introduced the portable BioFlash biological aerosol collection, detection and identification system for 21 biological threat agents.
St. Louis, MO 3/7/08—Sigma-Aldrich and Oxford Biomedica have settled their patent litigation against Open Biosystems (see IBO 6/15/06). Under the confidential settlement, Open Biosystems will acquire certain license rights for use of Oxford BioMedica’s LentiVector gene delivery technology in research activities. Other details were not disclosed.
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
